ArticleFrontiers in oncology2023

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12

Michal Mego et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.